| Feb 26, 2024 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum will be attending the 2024 BIO CEO & Investor Conference, New York, NY, February 26-27, 2024 |
| Nov 14, 2023 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum invited to speak on, “Big Things Come in Small Packages: Non-Viral Delivery of siRNA across BBB for CNS Indications”, at 2nd Annual Non-Viral RNA Delivery Systems Summit, Boston, MA. |
| May 22, 2023 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum is invited Leader for Discussion Group, “Drug Delivery to the Brain”, to be held virtually on Tuesday, February 28, 2023, from 10:00 A.M. - 11:00 A.M. EST. |
| Feb 28, 2023 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum is invited Leader for Group Discussion, “Drug Delivery to the Brain”, to be held virtually on Tuesday, February 28, 2023. |
| Oct 10, 2022 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum is invited to speak on, “V-Smart® Brain Delivery Trifecta for Biologics”, at Formulation & Delivery US", October 11-12 2022, San Diego, CA. |
| June 15,2022 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum is invited to speak on, “Uncovering Next Generation Drug Delivery Strategies for More Precise Weaponization of Oligonucleotides Against the CNS”, at 2nd Annual Oligonucleotides for CNS, June 15, 2022, Boston, MA. |
| June 13, 2022 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum is invited to speak on, “Novel Non-Invasive Targeted RNA Delivery to the CNS”, at RNA Therapeutics & Delivery U.S.: In-Person, June 13 - 14, 2022, Boston, MA. |
| May 18, 2022 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum invited Moderator at 2022 US East Coast CNS Therapeutics Xchange, Wednesday, May 18, 2022, 9:05 A.M. EST, Boston, MA/Virtual, |
| May 10, 2022 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum will be Emerging Life Sciences Company Presenter on May 10th at BioNJ’s 12th Annual BioPartnering Conference, co-sponsored by J.P. Morgan and J&J Innovation, to be held online May 9 - 13, 2022. |
| Jan 18, 2022 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum is invited Leader for Group Discussion, “Novel Delivery Technologies for mRNA-based Therapeutics”, to be held virtually on Tuesday, January 18, 2022, from 10:00 A.M. - 11:00 A.M. EST. |
| Nov 3, 2021 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum to present on, “V-Smart®: Novel Non-Invasive, Brain-Targeted Drug Delivery Platform”, at 2021 Global Drug Bioavailability Enhancement Summit to be held online November 3-4. |
| Oct 6, 2021 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum to present poster on, “LAUR-301 (V-Smart®-GDNF for ALS): Novel Non-Invasive, ALS-Targeted V-Smart® Nanomedicine Proves Effective in ALS Mice”, at 2021 Annual NEALS Meeting to be held online October 6-7 by Northeast ALS Consortium (NEALS). |
| Oct 4, 2021 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum to present on, “Lauren Sciences and V-Smart® Nanomedicine for Alzheimer’s Disease”, at 22nd International Conference on Alzheimer’s Drug Discovery to be held online October 4-5 by Alzheimer’s Drug Discovery Foundation (ADDF). |
| June 30, 2021 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum invited to speak on, “The Brain Delivery Trifecta: Triple Targeted, Non-Invasive CNS Platform for Non-BBB Penetrants”, Wednesday, June 30, 2021, 11:30 A.M. EST, 3rd Annual Blood-Brain Barrier Summit (Digital). |
| May 24, 2021 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum invited to lead roundtable discussion, “Exploring Current Opportunities of Shuttle Vehicles and Transcytosis Drug Delivery Technologies”, Wednesday, May 24, 2021, 1:40 P.M. EST, 2021 CNS Therapeutics Xchange. |
| May 19, 2021 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum invited to deliver presentation, “Global Solution Enables Nucleic-Acid-Based Therapeutics for Non-Invasive, Triple-Targeted Brain Delivery”, Wednesday, May 19, 2021, 11:30 A.M.(EST), 2021 American Association of Pharmaceutical Scientists (AAPS) National Biotechnology Conference (NBC). |
| Feb 23, 2021 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum invited to speak on “Developing a Strategy that Enables Oligonucleotides to Safely Move Across the Blood Brain Barrier in Order to Drive Therapeutic Success” on Tuesday, February 23, 9:00 A.M.(EST), at 1st Oligonucleotides for CNS Summit. |
| Dec 15, 2020 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum invited to speak on “V-Smart®: Non-Invasive Dual-Targeted BBB Delivery Solution for Non-Brain Penetrant CNS Therapeutic Agents” on Tuesday, December 15, 2:30 P.M.(ET), at 10th American Drug Delivery and Formulation Virtual Summit. |
| Sep 2, 2020 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum invited to speak on “V-Smart®: Non-Invasive, Dual-Targeted Delivery of Non-BBB Penetrant Therapeutic Agents to CNS” on Wednesday, September 2, 4:00 P.M., at virtual Blood-Brain Barrier Summit 2020. |
| Feb 11, 2020 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum will attend 2020 BIO CEO & Investor Conference, February 10-11, 2020, New York Marriott Marquis, and present on Tuesday, February 11, 9:00 A.M. |
| Aug 15, 2019 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum invited to speak on “Developing Non-Invasive, Dual-Targeted Brain Therapeutics for CNS Diseases Using V-Smart® Platform Technology” on Thursday, August 15, 10:45 A.M., at Blood-Brain Barrier Drug Delivery 2019, Boston, MA. |
| Jun 7, 2019 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum invited to speak on V-Smart® Nanomedicine for GBM @ 3:25 P.M., “Novel Applications and Treatments for Malignant Glioma” session, Brain Tumor Biotech Summit 2019, June 7, New York, NY. |
| Jun 2, 2019 |
Lauren Sciences Won 1st Place at China Focus Global Healthcare Innovation Competition during BIO 2019 in Philadelphia, PA. |
| May 15, 2019 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum invited to speak on V-Smart® Nanomedicines for “Parkinson’s and Other Movement Disorders” @ 2:00 P.M on May 22, Neurotech Conference, May 21-22, 2019, Boston, MA. |
| Oct 15, 2018 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum invited to present on Lauren Sciences LLC, a BIO International 2018 winner, at BIO Investor Forum, CNS/Neurological track, October 17-18, 2018, San Francisco, California. |
| Aug 21, 2018 |
Lauren Sciences CEO Rosenbaum Invited to Present to NIH and DOD: Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum invited to present talk on, “V-Smart® Nanomedicine Platform Technology: Non-invasive, Targeted Brain Delivery of Non-Brain Penetrant Agents for Treatment of CNS Diseases”, at interagency workshop meeting on “Infectious Disease in CNS and Therapeutic Strategies to Cross BBB” co-sponsored by National Institutes of Health (NIH) and Department of Defense (DOD) on August 21-22, 2018 in Rockville, MD. |
| July 25, 2018 |
BIO, biotechnology industry’s leading organization, announces Lauren Sciences as one of the winners at forum held during BIO’s 25th International Convention in June in Boston, MA. |
| July 24, 2018 |
Lauren Sciences developed LAUR-008 (V-Smart®-Human IgG Antibody).
LAUR-008 encapsulates and delivers antibody across BBB into brain by systemic administration. Percentage of hIgG dose in brain from LAUR-008 proves significantly higher than from free hIgG. Preliminary data on LAUR-008 presented in Poster 150 at Controlled Release Society (CRS) 2018 Annual Meeting, New York. |
| Jun 19, 2018 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum invited to present, “V-Smart® Nanomedicines: Non-Invasive Targeted Therapeutics for Brain Diseases”, and moderate, “Reduce, Reuse, Recycle Pharma Proprietary Therapeutic Agents for New Life in CNS Diseases”, at World Preclinical Congress, June 19-20, 2018, Boston, MA |
| Jun 5, 2018 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum to present on Tuesday, June 5, 2018, at 25th BIO International Convention, June 4-7, 2018, Boston, MA |
| May 2, 2018 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum to present keynote address, “V-Smart® Nanomedicines: Non-Invasive Targeted Therapeutics for Brain Diseases”, at 8:30 A.M., and to moderate, “Nanotechnology in Drug Delivery”, at 8:00 A.M., on Wednesday, May 9, 2018, at 4th Annual Formulation & Drug Delivery Congress, May 8-9, 2018, London, UK. |
| Apr 18, 2018 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum to present “V-Smart® Nanomedicines: Non-Invasive Targeted Brain Therapeutics” during Frontiers in Neurotechnology session, Wednesday, May 2, 2018, 2:00 PM, at Neurotech Investing and Partnering Conference, May 1-2, 2018 Boston, MA. |
| Mar 8, 2018 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum invited to speak on “V-Smart® Nanomedicines: Non-Invasive Targeted Brain Therapeutics” at 3rd Annual Drug Development Summit to be held March 8, 2018 in Parsippany, New Jersey. |
| Feb 21, 2018 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum invited to speak on “V-Smart® Nanomedicines: Non-Invasive, Targeted Brain Therapeutics for CNS Diseases” in development track “Therapeutic Strategies for Effectively Crossing the Blood Brain Barrier” at 6th World CNS Summit: Targeting Neurodegenerative Diseases held February 21-22, 2018 in Boston. |
| Jan 22, 2018 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum invited to chair track entitled, “Drug Delivery Technologies to Watch II”, and speak on “Lauren Sciences’ Novel V-Smart® Nanomedicines: Non-Invasive, Targeted Brain Delivery for CNS Diseases” at Drug Delivery Partnerships 2018, January 22-24, 2018, Palm Beach Gardens, Florida. |
| Nov 15, 2017 |
Lauren Sciences LLC is invited to present Poster 670.03, W11, entitled, “V-Smart® Nanomedicine for the Treatment of ALS (LAUR-301): Non-Invasive Targeted Delivery of GDNF to Degenerating Motoneurons in ALS”, at Society for Neuroscience 2017 Annual Meeting, in Washington. D.C. |
| Sep 6, 2017 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum invited to speak at Curtis & Coulter’s “3rd Drug Delivery Strategies: Advanced Mechanisms & Product Design Summit”, September 6-7, 2017, Philadelphia. Ms. Rosenbaum presents, “Next Generation: Non-Invasive Targeted Delivery of V-Smart™ Nanomedicines to the Brain”. |
